Skip to content

Clinical trials

Thrombocythemia, Essential trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocythemia, Essential Phase: Not applicable Country / region: United States Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20081
20091
20101
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated2
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center2
University of California, San Francisco2
Wake Forest University Health Sciences2
Brigham and Women's Hospital1
City of Hope Medical Center1
M.D. Anderson Cancer Center1
University of California, Irvine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polycythemia Vera10
Primary Myelofibrosis10
Thrombocythemia, Essential10
Myeloproliferative Disorders8
Congenital Abnormalities7
Leukemia, Lymphocytic, Chronic, B-Cell7
Leukemia, Myeloid, Chronic-Phase7
Leukemia, Myelomonocytic, Chronic7
Leukemia, Prolymphocytic7
Lymphoma, Large B-Cell, Diffuse7

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.